One year treatment with exenatide improves β cell function and glycaemic control in metformin treated type 2 diabetes patients

被引：0
|
作者：
Bunck, M. C.
Diamant, M.
Corner, A.
Eliasson, B.
Malloy, J. L.
Shaginian, R. M.
Deng, W.
Kendall, D. M.
Taskinen, M.-R.
Smith, U.
Yki-Jarvinen, H.
Heine, R. J.
机构：
[1] Vrije Univ Amsterdam, Dept Endocrinol, Med Ctr, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, S-41345 Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Houten, Netherlands
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0251
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [41] The effect of dietary fiber on glycaemic control in patients with type 2 diabetes on metformin monotherapy
    Tramontana, F.
    Maddaloni, E.
    Greci, S.
    Defeudis, G.
    Strollo, R.
    Pozzilli, P.
    Napoli, N.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S105 - S105
  • [42] Exenatide : one year of treatment improves the beta-cellular fuction in type 2 diabetics
    Sauvanet, J. -P.
    DIABETES & METABOLISM, 2007, 33 (05)
  • [43] Early Liraglutide Treatment Improves β-Cell Function in Patients With Type 2 Diabetes
    Kondo, Yoshinobu
    Satoh, Shinobu
    Inoue, Yuichiro
    Kimura, Masayo
    Hirama, Masayuki
    Nezu, Uru
    Terauchi, Yasuo
    DIABETES, 2013, 62 : A264 - A264
  • [44] Early Lixisenatide Treatment Improves β-cell Function in Patients with Type 2 Diabetes
    Kondo, Yoshinobu
    Satoh, Shinobu
    Terauchi, Yasuo
    DIABETES, 2016, 65 : A275 - A275
  • [45] Effects of exenatide plus rosiglitazone on measures of beta cell function and insulin sensitivity in subjects with type 2 diabetes previously treated with metformin
    Glass, L. C.
    Triplitt, C.
    Lewis, M. S.
    Qu, Y.
    Guo, Y.
    Maggs, D.
    DeFronzo, R. A.
    DIABETOLOGIA, 2009, 52 : S286 - S286
  • [46] Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
    DeFronzo, Ralph A.
    Triplitt, Curtis
    Qu, Yongming
    Lewis, Michelle S.
    Maggs, David
    Glass, Leonard C.
    DIABETES CARE, 2010, 33 (05) : 951 - 957
  • [47] Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
    Ratner, R. E.
    Maggs, D.
    Nielsen, L. L.
    Stonehouse, A. H.
    Poon, T.
    Zhang, B.
    Bicsak, T. A.
    Brodows, R. G.
    Kim, D. D.
    DIABETES OBESITY & METABOLISM, 2006, 8 (04): : 419 - 428
  • [48] Saxagliptin improves glycaemic control as monotherapy in type 2 diabetes
    List, J.
    Rosenstock, J.
    Sankoh, S.
    Chen, R.
    DIABETOLOGIA, 2007, 50 : S367 - S367
  • [49] Tetrahydrocannabivarin (THCV) improves glycaemic control in Type 2 diabetes
    Jadoon, K. A.
    Ratcliffe, S.
    O'Sullivan, S. E.
    Tan, G. D.
    DIABETIC MEDICINE, 2014, 31 : 67 - 67
  • [50] Treatment intensification for patients with type 2 diabetes and poor glycaemic control
    Fu, A. Z.
    Sheehan, J. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 892 - 898
12345